You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Harvard Business School
Dow
Express Scripts
Baxter

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

PREVANTICS MAXI SWABSTICK Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Prevantics Maxi Swabstick patents expire, and what generic alternatives are available?

Prevantics Maxi Swabstick is a drug marketed by Prof Dspls and is included in one NDA.

The generic ingredient in PREVANTICS MAXI SWABSTICK is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.

Summary for PREVANTICS MAXI SWABSTICK
Drug patent expirations by year for PREVANTICS MAXI SWABSTICK
Generic Entry Opportunity Date for PREVANTICS MAXI SWABSTICK
Generic Entry Date for PREVANTICS MAXI SWABSTICK*:
Constraining patent/regulatory exclusivity:
FDA exclusivity
NDA:
Dosage:
SWAB;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for PREVANTICS MAXI SWABSTICK

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Professional Disposables International, Inc.Phase 3

See all PREVANTICS MAXI SWABSTICK clinical trials

US Patents and Regulatory Information for PREVANTICS MAXI SWABSTICK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prof Dspls PREVANTICS MAXI SWABSTICK chlorhexidine gluconate; isopropyl alcohol SWAB;TOPICAL 021524-003 Jun 3, 2005 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
McKinsey
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.